Phase 2 study of targeted intravenous busulfan (IV BU) combined with fractionated total body irradiation (FTBI) and etoposide (VP-16) as preparative regimen for allogeneic peripheral blood stem cell transplant (PBSCT) for patients with poor risk leukemia

✍ Scribed by A.S. Stein; M.R. O’Donnell; A. Dagis; A. Krishnan; A. Nademanee; R. Nakamura; P.M. Parker; L. Popplewell; V. Pullarkat; R. Rodriguez; J. Rosenthal; E.P. Smith; D.S. Snyder; R. Spielberger; T. Synold; N. Vora; J. Zain; C. Sarkodee-Adoo; S.J. Forman

• Book ID: 116278552
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 58 KB
• Volume: 12
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2005.11.108